Confirmatory study on the retention rate of ketogenic diet therapy and related factors in children with drug‐resistant epilepsy: A single‐center cohort study
Open Access
- 19 June 2025
- journal article
- Published by Wiley in Epilepsia Open
- Vol. 10 (4) , 1147-1160
Abstract
Objective: To confirm the retention rate of ketogenic diet therapy (KDT) in children with drug‐resistant epilepsy and identify its related factors through a cohort analysis. Methods: This was a single‐center cohort study. Baseline data were collected, and regular follow‐up was conducted after KDT treatment. The retention rate of KDT at different time points was determined. Cox regression analyses and other statistical methods were used to identify the factors related to the retention rate. Results: A total of 337 patients were included. 43.3% (146/337) of the patients had only spasms, 16.9% (57/337) had a genetic etiology, and 14.0% (47/337) had a structural etiology. Overall, 51.9% (175/337) of the patients were classified as having infantile epileptic spasm syndrome. The median age at KDT initiation was 33 months. 38.3% (129/337) of the patients responded to KDT. The retention rate of KDT at 3, 6, 12 and 24 months were 86.6% (292/337), 62.6% (211/337), 35.0% (118/337), and 20.2% (68/337), respectively. 9.9% (56/282) stopped the treatment due to unsatisfactory seizure control and 54.6% (154/282) stopped due to a non‐response. The retention rate in patients who responded to KDT was relatively greater than that in patients who did not respond to KDT [HR: 4.714 (95% CI: 3.493, 6.362), p < 0.001]. The retention rate of KDT at 3 months was associated with seizure type and anti‐seizure efficacy. The retention rate of KDT at 6 months was associated with seizure type, status epilepticus and anti‐seizure efficacy. The retention rate of KDT at 12 and 24 months were both associated with anti‐seizure efficacy. Significance: Anti‐seizure efficacy was the sole independent predictor of long‐term retention. This large‐scale cohort study advances the field by demonstrating the predominant role of efficacy in long‐term adherence. The cohort size ( N = 337), one of the largest reported, strengthens evidence that the long‐term retention rate (>1 year) can be used as an important indicator to evaluate the efficacy of KDT, which is simple and reliable.Keywords
This publication has 14 references indexed in Scilit:
- Feasibility, tolerability and efficacy of the ketogenic diet in children with drug‐resistant epilepsy in VietnamEpilepsia Open, 2023
- Efficacy and Safety of Dietary Therapies for Childhood Drug-Resistant EpilepsyJAMA Pediatrics, 2023
- Efficacy, Retention Rate, and Influencing Factors of Ketogenic Diet Therapy in Children with Refractory Epilepsy: A Retrospective StudyNeuropediatrics, 2022
- Clinical implementation of ketogenic diet in children with drug-resistant epilepsy: Advantages, disadvantages, and difficultiesSeizure: European Journal of Epilepsy, 2022
- Ketogenic diet in pediatric seizures: a randomized controlled trial review and meta-analysisExpert Review of Neurotherapeutics, 2022
- Improving the effects of ketogenic diet therapy in children with drug-resistant epilepsySeizure: European Journal of Epilepsy, 2022
- Use of ketogenic diet therapy in infants with epilepsy: A systematic review and meta‐analysisEpilepsia, 2020
- Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study GroupEpilepsia Open, 2018
- A pragmatic study on efficacy, tolerability and long term acceptance of ketogenic diet therapy in 74 South Indian children with pharmacoresistant epilepsySeizure: European Journal of Epilepsy, 2018
- Long-term clinical outcomes and economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsyEpilepsy Research, 2017